Project Grant R01DA061841
Award Date
7/15/25
Completion Date
3/31/30
Dollars Obligated
$824K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Oregon, USA
Similar Awards
The National Institute on Drug Abuse (NIDA) awarded a $742,500 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), for a 3-year pilot study. The grant will fund the adaptation and pilot testing of a peer recovery coach-delivered tobacco cessation intervention, called PEERTTS, for individuals with opioid use disorder (OUD) and tobacco use disorder (TUD). The project aims to evaluate the...
The National Institute on Drug Abuse (NIDA) awarded a $770,751 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Oregon Health & Science University (OHSU) with a period of performance from July 1, 2025 to March 31, 2030. The grant supports research to examine the impact of telehealth expansion on access to and utilization of opioid use disorder (OUD) treatment within community health centers (CHCs). The study will use over 10 years of electronic health...
This Project Grant award of $3,257,011 from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), will fund a randomized controlled trial to evaluate the effectiveness of switching to electronic nicotine delivery systems (ENDS) compared to nicotine replacement therapy (NRT) for promoting smoking abstinence among individuals enrolled in substance use disorder (SUD) treatment programs in South Carolina. The study aims to: 1) assess...
The National Institute on Drug Abuse (NIDA) awarded a $863,837 Project Grant under CFDA 93.279 (Drug Use and Addiction Research Programs) to the National Opinion Research Center (NORC) to study the effects of alternative tobacco product marketing on social media platforms like Instagram, Facebook, and TikTok, and its impact on tobacco use among youth and young adults. The project aims to: 1) identify and characterize social media content related to alternative tobacco products, 2) assess the...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $149,000.00 to the University of Oregon to conduct a longitudinal study examining the effects of prenatal cannabis and tobacco co-exposure, as well as postnatal adversity, on child regulation and the potential buffering role of sensitive parenting. The research will assess changes in parasympathetic nervous system functioning from infancy...
This Project Grant award of $431,643, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports the development and pilot testing of a telehealth-delivered, pain-targeted motivational smoking intervention for smokers with chronic pain who are not ready to quit. The project aims to adapt an existing in-person intervention to a telehealth format and evaluate its feasibility and acceptability in a pilot randomized controlled...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a multi-method study to determine the addiction potential of concept-flavored cigarillos among young adult cigarillo users. The $752,701 award, with a project period from August 2025 to May 2030, will examine how cigarillo flavor type (concept, characterizing, tobacco) and flavor additives impact product appeal, smoking behavior, and...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $425,636 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to conduct patient-oriented substance use and smoking cessation research in the context of HIV treatment and prevention. The key activities funded under this 5-year award include: 1) Mentoring junior researchers (pre- and post-doctoral fellows,...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $395,566 to Flik Therapeutics, Inc. to support the development of a novel FDA-regulated pharmacotherapy and multimodal nicotine cessation program. The goal is to create a more effective smoking cessation therapy compared to the current standard of care, which has low success rates. This Phase I proposal will fund the initial development of the...
The federal Project Grant award with ID DP2DA062283 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $2,542,500 grant, awarded on September 1, 2024, will support the development of novel econometric methods and a unified framework for integrating real-world evidence (RWE) to analyze inconclusive randomized controlled trials (RCTs) focused on opioid use disorder (OUD) treatments. The project, to be conducted by Weill...